Latest Data Release and Publications:
Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancer. Filip Mundt, Sandeep Rajput, Shunqiang Li, Kelly Ruggles, Arshag D. Mooradian, Philipp Mertins et al., Cancer Res, in press (2018).
CPTAC colon cancer confirmatory study with global proteome and phophoproteome analyses.
Please install the latest Aspera Connect Client software (3.7) here.